Back to We fund priority-driven research through a combination of competitive research grants and by proactively identifying promising research and critical knowledge gaps that do not fit into traditional funding mechanisms.
Through the Cure Brain Cancer Foundation application process, we aim to provide funding for the projects with the greatest potential impact for patients.
Grant applications are assessed by our internationally renowned Scientific Advisory Committee, which advises on research projects that will deliver the greatest impact to people with brain cancer. Read more about our Scientific Advisory Committee here.
Learn more about some of the projects we help fund and hear from the researchers working on them by searching below.
We fund priority-driven research through a combination of competitive research grants and by proactively identifying promising research and critical knowledge gaps that do not fit into traditional funding mechanisms.
Through the Cure Brain Cancer Foundation application process, we aim to provide funding for the projects with the greatest potential impact for patients.
Grant applications are assessed by our internationally renowned Scientific Advisory Committee, which advises on research projects that will deliver the greatest impact to people with brain cancer. Read more about our Scientific Advisory Committee here.
Learn more about some of the projects we help fund and hear from the researchers working on them by searching below.
2021 Early Career Fellowship: Dr Yolanda Sanguino
2017 Early Career Fellowship: Dr Laura Genovesi
Breast and Brain Collaborative Grant
Research We Fund
NICHE HGG Clinical Trial Grant
Cure Brain Cancer Foundation’s 2020 contribution to the DIPG Collaborative
Genetic markers of clinical aggressiveness in glioblastoma and anaplastic oligodendroglioma
Developing a new animal model for malignant gliomas
Mechanisms of initiation and prevention of brain tumours
Underexpression of prostaglandin D synthase: a key molecular event in the transition of a low grade astrocytoma to an anaplastic astrocytoma
Consequences of loss of ADAM22 in brain tumour formation
Pilot study to evaluate the role of Tks5 in malignant glioma invasion
